Blood biomarkers for Alzheimer’s disease in clinical practice and trials
Oskar Hansson(Eli Lilly (United States)), Jeffrey L. Dage(Indiana University School of Medicine)
Cited by 443
Related Papers
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
|Alzheimer s & Dementia|2024|2.3k
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease
|The Journal of Prevention of Alzheimer s Disease|2022|1.3k
Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
|Nature Communications|2017|927
Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets
|Nature Immunology|2023|724
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
|The Lancet Neurology|2017|630